Delivery Order SPE2DB22D2006-SPE2DB23FW2FZ
Award Date 8/17/23
Potential Completion Date 8/18/23
Potential Value $738
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at approximately $1,460 to Amerisourcebergen Drug Corporation for the supply of 4561920381 GUAIFENESIN-PSE ER 600-60 MG 18S. The firm fixed price order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services in support of DLA missions. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 23 to August 24, 2023. No...
- The Defense Logistics Agency awarded a $455 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562163843 GUAIFENESIN-PSE ER 600-60 MG 36S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements. The single day period of performance from September 13 to 14, 2023 indicates this is likely a small order under the DLA's prime...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,208.12 on September 4, 2025, for the supply of Guaifenesin ER 600 mg tablets (500-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 5, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution...
- The Defense Logistics Agency awarded a $824 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562019085 GUAIFENESIN-PSE ER 600-60 MG 18S. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical product from its Conshohocken, Pennsylvania facility to support DLA's medical supply needs. No major subcontractors or set aside designations were indicated. This order is consistent with DLA's mission to provide medical logistics support...
- The Defense Logistics Agency awarded a $2,392.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Guaifenesin-PSE ER 600-60 mg tablets (18 count) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside, competitively awarded delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,490.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4,562,194,000 units of guaifenesin-pse extended release 600-60 mg tablets packaged in 18-count blister packs. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning September 15, 2023 through September 18, 2023. No set aside designation or subcontracting...
- The Defense Logistics Agency awarded a $29,550 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mg guaifenesin tablets. Under this order, Amerisourcebergen will deliver 100 bottles of the specified cough medication to a facility in Conshohocken, Pennsylvania by June 30, 2023 to support Department of Defense logistics operations. As a major pharmaceutical supplier, Amerisourcebergen frequently fulfills delivery orders for standard medical supplies through the DLA's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Guaifenesin ER 600 mg tablets (500 count) with a ceiling value of $1,419.55. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Guaifenesin 600mg tablets (500 count) with a ceiling value of $3,028.65. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on May 20, 2025, and will be performed at AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency Troop Support Medical awarded a $3,444.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for guaifenesin extended-release 100 mg tablets. The contract has a period of performance from July 18, 2023 through July 21, 2023, with all work to be performed by the prime contractor in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FW2FZDelivery Order
The Defense Logistics Agency awarded a $737 delivery order to Amerisourcebergen Drug Corporation for 4561851739 GUAIFENESIN-PSE ER 600-60 MG 18S. The firm fixed price order is being fulfilled from the contractor's Conshohocken, Pennsylvania location to support DLA's medical supply needs. No additional details were provided regarding the original solicitation, but the award is for a pharmaceutical product to replenish Defense Department medical stock. Amerisourcebergen will serve as the prime contractor to deliver the guaifenesin tablets to DLA by the completion date of August 18, 2023.
Generated 12/23/23, 10:29 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $738 | 8/17/23 |